Home / GLENMARK.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does GLENMARK.NS make money? Does GLENMARK.NS have pricing power? What's the Earnings Whisper? Will GLENMARK.NS profit more as the business scales? What is GLENMARK.NS's management track record? Is GLENMARK.NS's current price justified?

Glenmark Pharmaceuticals Limited

₹2226.7 +$200.50 (+9.90%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹2250.5

Day Range

₹2223.7₹2266.9

Year Range

₹1792.6₹2537.6

Market Cap

628.43B

AVG Volume

559.04K

Trailing/Forward PE

34.95/22.36

PEG ratio

-1.97

Dividend Yield

0.22%

Next Earnings Date

2026-11-06

Primary Exchange

National Stock Exchange of India

Revenue (INR) · A

GLENMARK.NS Revenue (INR) by year
Period	Revenue (INR)
2026	169.83B
2025	132.92B
2024	130.11B
2023	126.17B
2022	123.05B
2021	108.85B
2020	106.57B
2019	98.65B
2018	90.74B
2017	90.53B

Net Income (INR) · A

GLENMARK.NS Net Income (INR) by year
Period	Net Income (INR)
2026	13.62B
2025	10.47B
2024	-15.02B
2023	2.97B
2022	9.42B
2021	9.7B
2020	7.76B
2019	9.25B
2018	8.04B
2017	9.16B

Operating Income (INR) · A

GLENMARK.NS Operating Income (INR) by year
Period	Operating Income (INR)
2026	34.09B
2025	41.13B
2024	36.71B
2023	40.81B
2022	35.6B
2021	29.1B
2020	26.25B
2019	20.41B
2018	22.11B
2017	14.79B

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (INR) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Glenmark Pharmaceuticals Limited

Video analysis: GLENMARK.NS

News: GLENMARK.NS

Similar companies